Clinical Trials on Coronavirus Disease-2019 in Japan
Total 6936 results
-
U.S. Army Medical Research and Development CommandNo longer availableCoronavirus Disease 2019United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
U.S. Army Medical Research and Development CommandNo longer availableTreatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)Severe Acute Respiratory Syndrome Coronavirus 2United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
ModernaTX, Inc.CompletedCoronavirus Disease (COVID-19)Japan
-
TakedaWithdrawnSurvey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 SymptomsCoronavirus Disease (COVID-19)Japan
-
TakedaCompleted
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
AstraZenecaCompleted
-
PfizerCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
Genova Inc.Tokyo Shinagawa HospitalRecruiting
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2Japan
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
Daiichi Sankyo Co., Ltd.Completed
-
Kitasato UniversityActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
Humanity & Health Medical Group LimitedTokyo University; Nihon University School of MedicineRecruiting
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
AstraZenecaIqvia Pty LtdCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompletedCOVID-19 Lower Respiratory InfectionJapan
-
Merck Sharp & Dohme LLCCompletedCoronavirus Disease (COVID-19)United States, Argentina, Brazil, Bulgaria, Colombia, Dominican Republic, Egypt, France, Guatemala, Hungary, Japan, Kenya, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, South Africa, Spain, Thailand, Turkey, Ukraine
-
BayerCompletedTreatment of Venous ThromboembolismJapan
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Kyoto University, Graduate School of MedicineKyoto Prefectural University of MedicineWithdrawnHypertension | Cardiovascular Disease | Vascular DiseaseJapan
-
Kyoto Prefectural University of MedicineCompletedStroke | Hypertension | Ischemic Heart Disease | Congestive Heart FailureJapan
-
CathWorks Ltd.CompletedMulti Vessel Coronary Artery DiseaseJapan
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Tokyo Medical and Dental UniversityActive, not recruiting
-
Jikei University School of MedicineUnknownHypertension | Ischemic Heart Disease | Congestive Heart FailureJapan
-
TakedaRecruitingCrohn's DiseaseJapan
-
Kumamoto UniversityActive, not recruitingCoronary Artery Disease | End Stage Renal DiseaseJapan
-
Takeshi MorimotoCompletedCoronary Artery DiseaseJapan
-
Takeshi MorimotoCompletedCoronary Artery DiseaseJapan
-
Hyogo College of MedicineWithdrawnCoronary Artery Disease | AtherosclerosisJapan
-
Hiroshima UniversityUnknownCardiovascular Diseases | Coronary Artery Disease | AtherosclerosisJapan
-
TakedaRecruiting